Kevin Michael Krause - Net Worth and Insider Trading
Kevin Michael Krause Net Worth
The estimated net worth of Kevin Michael Krause is at least $3,962 dollars as of 2024-06-21. Kevin Michael Krause is the Chief Strategy Officer of AN2 Therapeutics Inc and owns about 1,914 shares of AN2 Therapeutics Inc (ANTX) stock worth over $3,962. Details can be seen in Kevin Michael Krause's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Kevin Michael Krause has not made any transactions after 2024-01-09 and currently still holds the listed stock(s).
Transaction Summary of Kevin Michael Krause
Kevin Michael Krause Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kevin Michael Krause owns 1 companies in total, including AN2 Therapeutics Inc (ANTX) .
Click here to see the complete history of Kevin Michael Krause’s form 4 insider trades.
Insider Ownership Summary of Kevin Michael Krause
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ANTX | AN2 Therapeutics Inc | 2024-01-09 | Chief Strategy Officer |
Kevin Michael Krause Latest Holdings Summary
Kevin Michael Krause currently owns a total of 1 stock. Kevin Michael Krause owns 1,914 shares of AN2 Therapeutics Inc (ANTX) as of January 9, 2024, with a value of $3,962.
Latest Holdings of Kevin Michael Krause
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ANTX | AN2 Therapeutics Inc | 2024-01-09 | 1,914 | 2.07 | 3,962 |
Holding Weightings of Kevin Michael Krause
Kevin Michael Krause Form 4 Trading Tracker
According to the SEC Form 4 filings, Kevin Michael Krause has made a total of 2 transactions in AN2 Therapeutics Inc (ANTX) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in AN2 Therapeutics Inc is the sale of 7,417 shares on January 9, 2024, which brought Kevin Michael Krause around $149,378.
Insider Trading History of Kevin Michael Krause
- 1
Kevin Michael Krause Trading Performance
Kevin Michael Krause Ownership Network
Kevin Michael Krause Owned Company Details
What does AN2 Therapeutics Inc do?
Who are the key executives at AN2 Therapeutics Inc?
Kevin Michael Krause is the Chief Strategy Officer of AN2 Therapeutics Inc. Other key executives at AN2 Therapeutics Inc include 10 percent owner Adjuvant Global Health Technology Fund De, L.p. , director & Chief Executive Officer Eric Easom , and 10 percent owner Ra Capital Healthcare Fund Lp .
AN2 Therapeutics Inc (ANTX) Insider Trades Summary
Over the past 18 months, Kevin Michael Krause made 2 insider transaction in AN2 Therapeutics Inc (ANTX) with a net sale of 10,000. Other recent insider transactions involving AN2 Therapeutics Inc (ANTX) include a net sale of 223,880 shares made by Kabeer Aziz , a net sale of 223,880 shares made by Adjuvant Global Health Technology Fund De, L.p. , and a net purchase of 7,223 shares made by Eric Easom .
In summary, during the past 3 months, insiders sold 0 shares of AN2 Therapeutics Inc (ANTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 565,631 shares of AN2 Therapeutics Inc (ANTX) were sold and 1,787,778 shares were bought by its insiders, resulting in a net purchase of 1,222,147 shares.
AN2 Therapeutics Inc (ANTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
AN2 Therapeutics Inc Insider Transactions
Kevin Michael Krause Mailing Address
Above is the net worth, insider trading, and ownership report for Kevin Michael Krause. You might contact Kevin Michael Krause via mailing address: 369 27th Street, San Francisco Ca 94131.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
